Amdoxovir

Amdoxovir
Clinical data
ATC code	none;
Identifiers
	IUPAC name [(2R,4R)-4-(2,6-diaminopurin-9-yl)-1,3-dioxolan-2-yl]methanol;
CAS Number	145514-04-1 ;
PubChem CID	124088;
ChemSpider	110576 ;
UNII	54I81H0M9C;
KEGG	D02890 ;
ChEMBL	ChEMBL458876 ;
NIAID ChemDB	005431;
Chemical and physical data
Formula	C9H12N6O3
Molar mass	252.234 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES n2c1c(nc(nc1n(c2)[C@@H]3O[C@@H](OC3)CO)N)N;
	InChI InChI=1S/C9H12N6O3/c10-7-6-8(14-9(11)13-7)15(3-12-6)4-2-17-5(1-16)18-4/h3-5,16H,1-2H2,(H4,10,11,13,14)/t4-,5-/m1/s1 ; Key:RLAHNGKRJJEIJL-RFZPGFLSSA-N ;
	(verify)

Amdoxovir is a nucleoside reverse transcriptase inhibitor (NRTI) undergoing research for the treatment of HIV/AIDS. It was discovered by Raymond F. Schinazi (Emory University) and C.K. Chu (University of Georgia). It is being developed by RFS Pharma.[1] Currently, it is in Phase II clinical studies.

References

"Amdoxovir". AIDSmeds.com. January 13, 2009. Archived from the original on 2008-03-21. Retrieved March 21, 2008.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.